The present invention discloses herein a synergistic nutritional composition(s) for treating iron deficiency anemia. Particularly, the invention relates to synergistic nutritional composition comprising specific combination of iron fortificant and hepcidin antagonist present in an effective amount, wherein the iron ...

The present invention discloses novel pain relieving fatty acid amide compositions. Particularly, the invention relates to synergistic nutritional composition comprising specific combination of fatty acid amide with two hydrolytic enzymes inhibitors. More particularly, the invention discloses synergistic nutritional...

The present invention relates to synergistic bioactive compositions for enhancing cellular energy in aerobic or anaerobic conditions. Particularly, the invention relates to a synergistic bioactive composition comprising specific combination of purine nucleoside and hydrophilic pyridinecarboxamide compound(s) which a...

The present invention herein discloses potent synergistic compositions of vasoactive mediators enhancers for improving vascular endothelial function. Particularly, the invention relates to synergistic nutritional composition comprising exogenous blend of N1-methyl nicotinamide chloride and standardized red spinach ...

The present invention discloses herein a synergistic composition(s) of bioactive agents for optimizing cellular health. Particularly, a synergistic bioactive composition for optimizing cellular health, wherein the composition comprising therapeutic blend of betaine of thiol histidine and sirtuin activator(s) or sal...

The present invention relates to synergistic bioactive compositions for repairing nerve damage and controlling nerve pain. Particularly, the invention relates to potent bioactive compositions comprising of synergistic combination of fatty acid amide and pyrimidine nucleotides along with pharmaceutically acceptable ...

The invention disclosed herein relates to synergistic lipid controlling compositions. Particularly it relates to synergistic, non-statin medicinal compositions of therapeutically active substances for lipid profile management. More particularly, the present invention provides synergistic lipid controlling compositio...

The present invention discloses a synergistic nutritional composition(s) for pain management. Particularly, the invention relates to synergistic nutritional composition comprising specific combination of palmitoylethanolamide (PEA) and standardized red spinach extract enriched with nitrate content, present in the ...

The present invention disclosed herein provides synergistic nutritional neuroprotective compositions for ameliorating neural dysfunction. Particularly, the invention relates to synergistic, efficient, nutritional composition for comprising specific combination of decarboxylated L-arginine called agmatine sulphate an...

The present invention disclosed herein relates to synergistic compositions for cerebrovascular diseases. In particular, the invention relates to synergistic, efficient, composition for treating cerebral ischemia or stroke comprising specific combination of standardized celery seed extract (CSE) enriched with Dl-3-N-...

The invention disclosed herein relates to synergistic nutritional compositions for treating neurodegenerative diseases. Particularly, the invention relates to nutritional compositions comprising synergistic combination of crystalline form of a magnesium salt of L- threonic acid , uridine monophosphate (UMP) and sal...

The present invention disclosed herein relates to synergistic bioactive compositions for treating neurological disorders. Particularly, the invention relates to anti-ischemic nutritional compositions. More particular, the invention relates to synergistic, efficient, nutritional compositions for treating cerebral isc...

The invention disclosed herein relates to novel synergistic medicinal compositions for treating dysfunctional D-serine (DSR) signaling. Particularly the invention provides potent synergistic medicinal composition comprising combination of N-acetyl taurinate salt of divalent metal (M2+AT) as serine racemase enzyme (...

The invention disclosed herein relates to novel synergistic nutritional compositions for treating seizures and chronic inflammatory diseases. Particularly, the invention relates to potent and stable synergistic nutritional composition comprising combination of therapeutically active non-competitive amino-3-hydroxy-5...

Abstract of the Invention Novel Synergistic Nutritional Compositions for Promoting Axonal Regeneration The invention disclosed herein relates to a novel synergistic nutritional composition for promoting axonal regeneration. Particularly, the present invention provides potent nutritional composition comprising sy...

The invention disclosed herein relates to synergistic nutritional compositions for enhancing cellular ATP efficiency. Particularly, the invention relates to a synergistic, efficient, nutritional composition for promoting cellular ATP production comprising a therapeutically active exogenous combination of a stabilize...

The present invention relates to compositions for enhancing TFEB-mediated intracellular clearance. Particularly, the invention relates to complex comprising synergistic combination of polyamine and histidine-containing dipeptide present in a specific weight ratio along with pharmaceutically acceptable excipients. ...

The present invention herein discloses novel synergistic composition comprising SIRT1 and AMPK activators for treating metabolic syndrome. Particularly the composition comprising therapeutic blend of SIRT1 activator(s) and stabilized AMPK activator(s) present in the ratio of 1: 1 to 1: 5, along with pharmaceutically...

The invention disclosed herein relates to synergistic nutritional compositions for treating metabolic bone disorders. Particularly, the present invention provides an antiresorptive nutritional composition comprising synergistic combination of therapeutically active calcium-L-threonate and eldecalcitol, along with ph...

The present invention disclosed herein relates to a synergistic composition for potentiating stabilized ATP. Particularly, the invention provides the synergistic composition for improving cellular energy in a subject in need thereof. More particularly, the invention relates to compositions comprising synergistic com...

The invention disclosed herein related to an oral, algal oil-based, gastro-intestinal tract permeable peptide composition. Particularly, the invention relates to the oral, water in algal oil- based, peptide compositions for the treatment of glucose metabolic disorders comprising peptides that generally degraded in G...

Abstract of the Invention A Synergistic Composition For Activating Intracellular Secondary Messenger(cAMP) Pathway The invention discloses herein related to synergistic combination of exogenous bioactives for activating intracellular secondary messenger (cAMP) signalling pathway. Particularly, the invention re...

The invention disclosed herein relates to synergistic nutritional compositions for treating vestibular associated neurodegenerative diseases. Particularly, the invention relates to synergistic nutritional compositions comprising an exogenous blend of N-acetyl-DL-leucine (NADLL) enantiomerically enriched with L-leuci...

The invention disclosed herein related to novel synergistic nutritional compositions for treating neurocognitive disorders. Particularly, the invention provides stable nutritional composition for treating neurocognitive disorders comprising exogenous blend of magnesium L-threonate and homotaurine present in the weig...

Abstract of the invention A synergistic composition for inhibiting vascular calcification The invention disclosed herein relates to synergistic bioactive compositions for inhibiting vascular calcification. Particularly, the present invention relates to exogenous blend of magnesium 2-acetylamino ethane sulfonic...

The present invention discloses herein synergistic composition(s) of bioactive agents for improving female cellular health. Particularly, a synergistic bioactive composition for female cellular health, wherein the composition comprising synergistic combination of L-ergothioneine and Nicotinamide mononucleotide prese...

The invention disclosed herein relates to a bioactive composition useful in the treatment of neural tube defects (NTDs), attention and cognitive dysfunction, infant processing speed, visuospatial memory, congenital disabilities, ADHD, and autism. Particularly, the invention relates to synergistic combination of biol...

The present invention disclosed herein relates to the novel in-situ process for preparation of conjugate of magnesium with acetylated aminosulfonic acid with high purity and high yield. The process comprising steps of in-situ catalytic acetylation of aminosulfonic acid followed by conjugation of magnesium in presenc...

The present invention disclosed herein relates to stable synergistic bioactive composition for fetal development. Particularly, the present invention provides stable synergistic bioactive composition for improving choline expression for fetal development comprising exogenous combination of stabilized polyunsaturated...

The invention disclosed herein relates to synergistic composition for modulating expression of cyclic ADP ribose hydrolase (CD38). Particularly, the present invention relates to synergistic bioactive composition comprising therapeutic blend of bioactive sesquiterpenoid and at least one potent glucose uptake promoter...

The present invention relates to a synergistic composition for enhancing activity of PINK1/PARKIN pathway. Particularly, the present invention relates to synergistic bioactive composition comprising combination of benzo-coumarin compound and at least one cell viability enhancer along with pharmaceutically acceptable...

The present invention disclosed herein relates to synergistic composition for improving HPG axis activity. Particularly, the present invention relates to a synergistic bioactive composition comprising combination of 2-aminobutanedioic acid and one or more ROS inhibitors or salts thereof along with pharmaceutically a...

The present invention relates to a novel synergistic bioactive composition for treating abnormal electrical brain activity. The present invention relates to a synergistic bioactive composition comprising combination of AMPAR-NMDAR antagonist complex for treating abnormal electrical brain activity. Particularly, the ...

The invention disclosed herein relates to a synergistic composition for treating gastrointestinal inflammatory diseases. Particularly, the invention provides an effective polysaccharide ester mediated glucocorticosteroid therapy for treating gastrointestinal inflammation. The present invention provides a synergistic...

The invention disclosed herein relates to a bioactive nucleotide compound for regulating Lecithin-cholesterol acyltransferase (LCAT) activity in human and in situ process for preparation thereof. Particularly, the process comprising steps of in-situ esterification followed by phosphorylation and deprotection. Fu...

The present invention relates to a synergistic composition for the treatment of disorders related to central nervous system (CNS) excitability. The synergistic composition comprises combination of GABA receptor agonists and synaptic plasticity enhancer or salts thereof along with pharmaceutically acceptable excipien...

The present invention disclosed herein relates to novel selective pre-synaptic partial GABA-B-R1 agonist (SPPGA) compounds of a Formula I and simple commercially viable one pot process for preparation thereof. The selective pre-synaptic partial GABA-B-R1 agonist (SPPGA) of a Formula I include optically active is...